Market Access Specialty Pharmacy Accreditation: DCI’s Exclusive Analysis Reveals a Market at an Inflection Point Drug ChannelsThe Drug Channels Institute (DCI) team attended Asembia's AXS26 Summit last week.Read full story pharminent May 5, 2026 (Last updated: May 5, 2026) Drug Channels The Drug Channels Institute (DCI) team attended Asembia’s AXS26 Summit last week. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Lannett, Lanexa Biologics and Sunshine Lake secure FDA approval for LanglaraNext: Cytokinetics heart drug scores in closely watched trial Related Stories Market Access NICE aims to cut funding for Amgen lung cancer drug Lumykras pharminent July 9, 2026 Market Access UK, pharma industry pilot rapid access routes for medicines pharminent July 5, 2026 Market Access Medicare GLP-1 Bridge Launches July 1 With $50 Copays pharminent July 3, 2026
